Comprehensive CNS Cancer Panel near me in Hyderabad

The Comprehensive CNS Cancer Panel is a specialized diagnostic test designed to support accurate classification, molecular characterization, and personalized treatment planning for central nervous system (CNS) tumors. The package includes detailed histopathology reporting and expert review of up to 8 tissue blocks, incorporating essential immunohistochemistry (IHC) markers such as ATRX, p16, IDH R132, H3Kme3, H3K27M, and BRAF V1, which are critical for precise tumor subtyping and prognosis. It also includes TERT promoter mutation analysis, an important molecular marker associated with tumor aggressiveness and outcome. The IDH1/2 mutation test helps distinguish tumor subtype and reflex 1p/19q codeletion testing by FISH supports the classification of IDH-mutant oligodendroglioma, giving key therapeutic information. In addition, the package comprises MGMT promoter methylation testing, which helps predict response to alkylating chemotherapy and guides therapeutic decision-making, particularly in gliomas. Getting tested with the Comprehensive CNS Cancer Panel provides integrated pathology and molecular analyses for precision oncology, enabling clinicians to make informed, evidence-based treatment decisions to ensure that patients receive the most effective and individualized care in the management of CNS cancer.

Note: One representative block of the tumor is required. However, 1-4 representative blocks of tumors are acceptable.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.